We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Sep 2022
  • Code : CMI1270
  • Pages : 152
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global tumor ablation market size was valued at USD 1,018.6 million in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 11.5% from 2022 to 2028. The market is to propel the market as there is an increase in geriatric population, rising cases of cancer or the tumor. Complications linked with the tumor ablation therapy anticipated to hinder the market growth. Based on the segment the market is divided by technology, by treatment, by application.

Global Tumor Ablation Market: Regional Insights

Based on geography, the global tumor ablation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East &Africa., the North America region conquered the tumor ablation market. Main reasons causative to its growth comprise regulatory assistance for standard healthcare, huge purchasing power, accessibility of compensation, and rising frequency of malignancy in the U.S. and Canada.

Europe is responsible for notable market share in tumor ablation market. Greater amount of public spending in Europe’s healthcare system has donated to market growth. Furthermore, rising geriatric population and regulatory assistance to regulate malignancy have led to considerable market growth.

Figure 1. Global Tumor Ablation Market Share (%), by Region, 2021


Global Tumor Ablation Market Drivers:

Ablation is a therapy that damages liver cancer without eradicating it. This method is essential in patients having some small tumors and at times when operation is not a choice. Furthermore, patients getting such form of therapy mainly do not require to stay in healthcare, hence rising acquirement rate of ablation systems among people.

Increase in the frequency of several forms of malignancy such as breast carcinoma, colon cancer, prostate cancer, and lung cancer is expected to fuel the need for ablation machinery for therapy of cancer in renal, soft tissue, liver, and bone. Cancer is known as a universal healthcare difficulty as it is one of the main reason of fatality.

Global Tumor Ablation Market Opportunities:

Growing perception regarding ablation process through conventional therapeutics and surgical process is anticipated to fuel the global tumor ablation market forward and will offer advantageous opportunities for the tumor ablation market growth.

Furthermore, rise in the count of rising markets and increase in count of novel goods approved are propelling adequate of advantageous opportunities that will fuel the tumor ablation market further over the predicted duration.

Tumor Ablation Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 1,264.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 11.5% 2028 Value Projection: US$ 2,425.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Technology: Radiofrequency Ablation, Microwave Ablation, Cryo Ablation, Irreversible Electroporation, Laser Based Thermal Ablation, Other Ablation Technologies
  • By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
  • By Application: Kidney Cancers, Liver Cancers, Breast Cancers, Lung Cancers, Prostate Cancers, Colorectal Cancers, Other Cancers
Companies covered:

Medtronic, Johnson & Johnson Services Inc., Boston Scientific Corporation, IceCure Medical, EDAP TMS, Theraclion, H.S. Hospital Service SPA and AngioDyna mics.

Growth Drivers:
  • Increasing incidence of cancer
  • Technological advancements in ablation devices
Restraints & Challenges:
  • Complications associated with tumor ablation therapy

Global Tumor Ablation Market Trends:

Lung cancer is one of the main causes of death globally. There are two main forms small cell lung carcinoma and non-small cell lung carcinoma, based on how it takes place under a microscope. Non-small cell lung carcinoma is more usual than small cell lung carcinoma. The rising burden of lung carcinoma owing to rising unhealthy habits, and a surge in R&D actions, combined with the approval of goods, is fueling the market segment's growth. 

Rising medical analysis for lung carcinoma and ablation therapy is propelling the segment’s growth. For example, a research survey was introduced in December 2021 by Ethicon Inc. to calculate the efficiency and security of the novel wave-certus microwave ablation method in Chinese patients with initial or secondary cancer in the lung. The survey is anticipated to be finished by December 2024. 

Global Tumor Ablation Market Restraints:

Tumor ablation treatment has rising as a viable therapy choice for several solid organ cancer. With rising count of processes, complexities may also rise. Most usual side effects of ablation comprise of bleeding and target organ wound.

Anyhow, these side effects are categorized as per their related threat. Side effects linked with these operations can hinder the market growth. Ablation strategies come under clinical device Class II and III categories, as per Food and Drug Administration. These categories need huge control and observation.

Figure 2. Global Tumor Ablation Market Share (%), by Treatment, 2021


Global Tumor Ablation Market Segmentation:

The global tumor ablation market report is segmented by technology, by treatment, by application,

Based on the technology, the market is segmented into radio frequency ablation and microwave ablation and many more out of which in Radiofrequency ablation is a minimally intrusive and nonsurgical process executed on ambulatory basis to cure sacroiliac joint pain, back facet joints, and painful neck. Radiofrequency ablation technology provides various advantages.

The other one Microwave ablation comprises the usage of electromagnetic waves for tumor destruction, with the device having incidence of at least 900 MHz. It has several benefits over other machineries, in terms of efficiency in abolishing cancer cells. The benefits of this machinery comprise constancy in huge temperature, vast tumor ablation capacity, less ablation duration, decreased pain.

Based on the treatment, the market is segmented into surgical ablation and laparoscopic ablation out of which the Laparoscopic surgeries comprise of fixing of a thin tube from an incision on the belly. This method is utilized to cure cancer linked with abdominal organs, such as kidney and liver. This method utilizes special tools for small cuts to decrease recovery duration.

The other one software, surgical ablation process is a minimally intrusive therapy, whereas ablation catheters/probes are utilized to offer energy right to the malignancy site for therapy. This therapy does not comprise medical eradication of tumors or infected cells. It is conducted on sufferers experiencing problems in medical eradication of malignancy/carcinoma cells.

Based on application, the market is segmented into kidney cancer and liver cancer and many more in kidney cancer Microwave ablation and radiofrequency ablation treatments utilize image supervision to direct syringe from skin into renal cancer. In microwave ablation, microwaves are made from syringe to make small region of heat. The heat destructions and harms the tumorous kidney cells. In radiofrequency ablation, electrical signals with huge frequency are passed from electrode in syringe, creating small region of heat.

In liver cancer the therapy by ablation states in damaging tumor without excision. This is undertaken in sufferers who have few small cancer that cannot be clinically eliminated. When cancer size is much more than 3 cm, ablation is not advised, as this impacts normal tissues as well.

Global Tumor Ablation Market: Key Developments

In April 2021, Medtronic gains breakthrough appliances designation from the U.S. Food and Drug Administration for Emprint ablation catheter kit. This method assists the organization in reinforcing its product database.

In February 2017, Medtronic got Food and Drug Administration approval for OsteoCool RF ablation system. This system gained approval for palliative therapy of metastatic bone cancers.

In August 2020, Ethicon, a part of Johnson & Johnson, gained Food and Drug Administration breakthrough equipment title for microwave machinery. This plan helped the organization in improving its revenue generation.

Global Tumor Ablation Market: Key Companies Insights

The global tumor ablation market is highly competitive. This is attributed to continuous launch of new technologies due to ongoing R &D and efforts by value chain participants. Moreover, key players are adopting various business growth strategies in order to expand their presence on regional as well as global basis. Some of the key players in the global tumor ablation market are:

Medtronic, Johnson & Johnson Services Inc., Boston Scientific Corporation, IceCure Medical, EDAP TMS, Theraclion, H.S. Hospital Service SPA and AngioDyna mics.

*Definition: Tumor ablation is a minimally invasive surgical process to cure solid malignancy. Special probes are utilized to heat or freeze malignancy without the general operation. Computed Tomography, Ultrasound or Magnetic Resonance Imaging is utilized to guide and position the needle probe into the cancer. This needs only a tiny hole, generally below 3 mm through which the probe is presented.

Frequently Asked Questions

The global tumor ablation market size is estimated to be valued at US$ 1,264.0 Million in 2022 and is expected to exhibit a CAGR of 11.5% between 2022 and 2028.

Increasing incidence of cancer are fueling the growth of market.

The percutaneous ablation segment is the leading treatment segment in the market.

Complications associated with the tumor ablation therapy restraining growth of the market.

Major players in the market are Medtronic, Johnson & Johnson Services Inc., Boston Scientific Corporation, IceCure Medical, EDAP TMS, Theraclion, H.S. Hospital Service SPA and AngioDyna mics.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo